{"id":40495,"date":"2025-02-24T11:01:13","date_gmt":"2025-02-24T10:01:13","guid":{"rendered":"https:\/\/www.vismederiholding.com\/advancing-research-on-emerging-diseases-and-vaccines\/"},"modified":"2025-02-24T11:03:59","modified_gmt":"2025-02-24T10:03:59","slug":"advancing-research-on-emerging-diseases-and-vaccines","status":"publish","type":"post","link":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/","title":{"rendered":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti"},"content":{"rendered":"<p class=\"x_MsoNormal\"><span data-olk-copy-source=\"MessageBody\"><strong>VisMederi<\/strong> amplia il proprio pacchetto di test con <strong>piattaforme pseudo virali,<\/strong> uno strumento fondamentale per lo<strong> studio dell&#8217;immunogenicit\u00e0<\/strong> e lo sviluppo di vaccini contro virus emergenti e patogeni. <\/span><\/p>\n<p class=\"x_MsoNormal\"><span data-olk-copy-source=\"MessageBody\">Queste tecnologie avanzate ci permettono di valutare la risposta immunitaria in modo sicuro ed efficace, accelerando la ricerca verso nuove soluzioni preventive.<\/span><\/p>\n<div>\n<p class=\"x_MsoNormal\"><b>Nuove piattaforme pseudo virali attive:<\/b><\/p>\n<\/div>\n<p class=\"x_elementtoproof\">Seasonal Flu (Lenti)<\/p>\n<p class=\"x_elementtoproof\">Avian Flu (Lenti)<\/p>\n<p class=\"x_elementtoproof\">SARS_CoV-1(Lenti)<\/p>\n<p class=\"x_elementtoproof\">MERS-CoV (Lenti)<\/p>\n<p class=\"x_elementtoproof\">SARS-CoV-2(Lenti)<\/p>\n<p class=\"x_elementtoproof\">299E HCoV (Lenti)<\/p>\n<p class=\"x_elementtoproof\">Lassa Virus (Lenti)<\/p>\n<p class=\"x_elementtoproof\">Ebola Virus (Lenti-VSV)<\/p>\n<p class=\"x_elementtoproof\">Marburg Virus (Lenti-VSV)<\/p>\n<p class=\"x_elementtoproof\">Rift Valley Virus (VSV)<\/p>\n<p class=\"x_elementtoproof\">Rabies Virus (Lenti)<\/p>\n<p class=\"x_elementtoproof\">Chikungunya Virus (Lenti)<\/p>\n<p>&nbsp;<\/p>\n<div>\n<p class=\"x_MsoNormal\"><strong>Sono inoltre in fase di sviluppo nuove piattaforme pseudo-virali per:<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"x_MsoNormal\">Polio Virus<\/p>\n<\/div>\n<div>\n<p class=\"x_MsoNormal\">HPV<\/p>\n<\/div>\n<div>\n<p class=\"x_MsoNormal\">\n<\/div>\n<div>\n<p class=\"x_MsoNormal\">Questa espansione<strong> rafforza la nostra capacit\u00e0 di affrontare con tempestivit\u00e0 le sfide delle malattie emergenti<\/strong>, supportando partner e istituzioni nella lotta contro le minacce globali alla salute pubblica.<\/p>\n<\/div>\n<div>\n<p class=\"x_MsoNormal\">Vuoi saperne di pi\u00f9 sulle nostre piattaforme e collaborazioni? Contattaci!<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>VisMederi amplia il proprio pacchetto di test con piattaforme pseudo virali, uno strumento fondamentale per lo studio dell&#8217;immunogenicit\u00e0 e lo sviluppo di vaccini contro virus emergenti e patogeni. Queste tecnologie avanzate ci permettono di valutare la risposta immunitaria in modo sicuro ed efficace, accelerando la ricerca verso nuove soluzioni preventive. Nuove piattaforme pseudo virali attive: [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":40493,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[109],"tags":[133,116,157,206,170,120,123,165,185,128,159,160,135,188,151],"dipi_cpt_category":[],"class_list":["post-40495","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newseventi","tag-elisa-mennito-it","tag-emanuele-montomoli-it","tag-immunization-it","tag-influenza-it","tag-international-study-it","tag-meningitis-vaccine-project-it","tag-rd-projects-it","tag-research-it","tag-serological-testing-it","tag-siena-it","tag-vaccinations-it","tag-vaccine-it","tag-vaccine-development-it","tag-viral-vaccine-assessment-it","tag-vismederi-group-it"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding\" \/>\n<meta property=\"og:description\" content=\"VisMederi amplia il proprio pacchetto di test con piattaforme pseudo virali, uno strumento fondamentale per lo studio dell&#8217;immunogenicit\u00e0 e lo sviluppo di vaccini contro virus emergenti e patogeni. Queste tecnologie avanzate ci permettono di valutare la risposta immunitaria in modo sicuro ed efficace, accelerando la ricerca verso nuove soluzioni preventive. Nuove piattaforme pseudo virali attive: [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"Vismederi Holding\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T10:01:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T10:03:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"1130\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elec23\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elec23\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/\"},\"author\":{\"name\":\"Elec23\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/#\\\/schema\\\/person\\\/2001c2c9d347ea0b6f36abac39396e9c\"},\"headline\":\"Innovazione continua nella ricerca sui vaccini e le malattie emergenti\",\"datePublished\":\"2025-02-24T10:01:13+00:00\",\"dateModified\":\"2025-02-24T10:03:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/\"},\"wordCount\":153,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vismederiholding.com\\\/vh\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/thumbnail_image001.png\",\"keywords\":[\"Elisa Mennito\",\"Emanuele Montomoli\",\"Immunization\",\"influenza\",\"International Study\",\"Meningitis Vaccine Project\",\"R&amp;D projects\",\"research\",\"Serological Testing\",\"siena\",\"vaccinations\",\"vaccine\",\"vaccine development\",\"Viral Vaccine Assessment\",\"vismederi group\"],\"articleSection\":[\"News&amp;eventi\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/\",\"url\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/\",\"name\":\"Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vismederiholding.com\\\/vh\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/thumbnail_image001.png\",\"datePublished\":\"2025-02-24T10:01:13+00:00\",\"dateModified\":\"2025-02-24T10:03:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/#\\\/schema\\\/person\\\/2001c2c9d347ea0b6f36abac39396e9c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vismederiholding.com\\\/vh\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/thumbnail_image001.png\",\"contentUrl\":\"https:\\\/\\\/www.vismederiholding.com\\\/vh\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/thumbnail_image001.png\",\"width\":800,\"height\":1130},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/advancing-research-on-emerging-diseases-and-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovazione continua nella ricerca sui vaccini e le malattie emergenti\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/\",\"name\":\"Vismederi Holding\",\"description\":\"A group with expertise in the evaluation of vaccine immunogenicity\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/#\\\/schema\\\/person\\\/2001c2c9d347ea0b6f36abac39396e9c\",\"name\":\"Elec23\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g\",\"caption\":\"Elec23\"},\"url\":\"https:\\\/\\\/www.vismederiholding.com\\\/it\\\/author\\\/elec23\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/","og_locale":"it_IT","og_type":"article","og_title":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding","og_description":"VisMederi amplia il proprio pacchetto di test con piattaforme pseudo virali, uno strumento fondamentale per lo studio dell&#8217;immunogenicit\u00e0 e lo sviluppo di vaccini contro virus emergenti e patogeni. Queste tecnologie avanzate ci permettono di valutare la risposta immunitaria in modo sicuro ed efficace, accelerando la ricerca verso nuove soluzioni preventive. Nuove piattaforme pseudo virali attive: [&hellip;]","og_url":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/","og_site_name":"Vismederi Holding","article_published_time":"2025-02-24T10:01:13+00:00","article_modified_time":"2025-02-24T10:03:59+00:00","og_image":[{"width":800,"height":1130,"url":"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png","type":"image\/png"}],"author":"Elec23","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Elec23","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#article","isPartOf":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/"},"author":{"name":"Elec23","@id":"https:\/\/www.vismederiholding.com\/it\/#\/schema\/person\/2001c2c9d347ea0b6f36abac39396e9c"},"headline":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti","datePublished":"2025-02-24T10:01:13+00:00","dateModified":"2025-02-24T10:03:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/"},"wordCount":153,"commentCount":0,"image":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png","keywords":["Elisa Mennito","Emanuele Montomoli","Immunization","influenza","International Study","Meningitis Vaccine Project","R&amp;D projects","research","Serological Testing","siena","vaccinations","vaccine","vaccine development","Viral Vaccine Assessment","vismederi group"],"articleSection":["News&amp;eventi"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/","url":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/","name":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti - Vismederi Holding","isPartOf":{"@id":"https:\/\/www.vismederiholding.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#primaryimage"},"image":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png","datePublished":"2025-02-24T10:01:13+00:00","dateModified":"2025-02-24T10:03:59+00:00","author":{"@id":"https:\/\/www.vismederiholding.com\/it\/#\/schema\/person\/2001c2c9d347ea0b6f36abac39396e9c"},"breadcrumb":{"@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#primaryimage","url":"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png","contentUrl":"https:\/\/www.vismederiholding.com\/vh\/wp-content\/uploads\/2025\/02\/thumbnail_image001.png","width":800,"height":1130},{"@type":"BreadcrumbList","@id":"https:\/\/www.vismederiholding.com\/it\/advancing-research-on-emerging-diseases-and-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vismederiholding.com\/it\/"},{"@type":"ListItem","position":2,"name":"Innovazione continua nella ricerca sui vaccini e le malattie emergenti"}]},{"@type":"WebSite","@id":"https:\/\/www.vismederiholding.com\/it\/#website","url":"https:\/\/www.vismederiholding.com\/it\/","name":"Vismederi Holding","description":"A group with expertise in the evaluation of vaccine immunogenicity","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vismederiholding.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/www.vismederiholding.com\/it\/#\/schema\/person\/2001c2c9d347ea0b6f36abac39396e9c","name":"Elec23","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b961e9d0441215ad52989b36cbb5451ab4201ca0349f0b53b1080b8b365531a3?s=96&d=mm&r=g","caption":"Elec23"},"url":"https:\/\/www.vismederiholding.com\/it\/author\/elec23\/"}]}},"_links":{"self":[{"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/posts\/40495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/comments?post=40495"}],"version-history":[{"count":1,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/posts\/40495\/revisions"}],"predecessor-version":[{"id":40496,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/posts\/40495\/revisions\/40496"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/media\/40493"}],"wp:attachment":[{"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/media?parent=40495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/categories?post=40495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/tags?post=40495"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/www.vismederiholding.com\/it\/wp-json\/wp\/v2\/dipi_cpt_category?post=40495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}